PCM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.65630000004136E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.73211999999756E-05 |
Normal-vs-Stage2 |
4.214700E-04 |
Normal-vs-Stage3 |
1.807860E-04 |
Normal-vs-Stage4 |
3.363500E-04 |
Stage1-vs-Stage2 |
6.552800E-01 |
Stage1-vs-Stage3 |
7.939000E-01 |
Stage1-vs-Stage4 |
4.796200E-01 |
Stage2-vs-Stage3 |
8.212400E-01 |
Stage2-vs-Stage4 |
6.927400E-01 |
Stage3-vs-Stage4 |
5.223200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.10499999994573E-06 |
Normal-vs-AfricanAmerican |
5.836800E-04 |
Normal-vs-Asian |
9.848500E-04 |
Caucasian-vs-AfricanAmerican |
5.512200E-01 |
Caucasian-vs-Asian |
1.307440E-01 |
AfricanAmerican-vs-Asian |
7.244400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.04430000039224E-07 |
Normal-vs-Female |
5.641800E-02 |
Male-vs-Female |
1.444390E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.448300E-04 |
Normal-vs-Extreme_Weight |
1.35450000005033E-06 |
Normal-vs-Obese |
2.195600E-03 |
Normal-vs-Extreme_Obese |
3.71319999999953E-05 |
Normal_Weight-vs-Extreme_Weight |
4.604000E-01 |
Normal_Weight-vs-Obese |
5.182200E-01 |
Normal_Weight-vs-Extreme_Obese |
1.886560E-01 |
Extreme_Weight-vs-Obese |
1.199360E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.675200E-01 |
Obese-vs-Extreme_Obese |
9.573600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.081600E-01 |
Normal-vs-Age(41-60Yrs) |
5.422700E-04 |
Normal-vs-Age(61-80Yrs) |
7.61449999719943E-08 |
Normal-vs-Age(81-100Yrs) |
3.554200E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.170200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.270200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.550100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.658120E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.352630E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.086200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.5170999999925E-05 |
Normal-VS-Type2 PRCC |
1.2080000000303E-06 |
Normal-VS-KIRP CIMP |
9.893400E-01 |
Normal-VS-Unclassified PRCC |
3.796300E-03 |
Type1 PRCC-VS-Type2 PRCC |
1.405180E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.974800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.580800E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.190190E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.295800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.391360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.0529999922303E-09 |
Normal-vs-N1 |
1.152580E-01 |
Normal-vs-N2 |
2.169000E-01 |
N0-vs-N1 |
7.118400E-02 |
N0-vs-N2 |
1.175760E-01 |
N1-vs-N2 |
9.824400E-01 |
|
|